Monday, November 23, 2009

Diabetes Home>
News>
FDA: Some glucose monitoring test results could be wrong

Font size
- A
- A
- A
Email This

Bookmark

Save

Shedding Light on the Co-morbidities of DiabetesThe Complications of Having Rheumatoid Arthritis and Diabetes

FDA: Some glucose monitoring test results could be wrong

(The Associated Press) UPDATED 2009-08-14

The U.S. Food and Drug Administration (FDA) says that people on dialysis, or who take biologic drugs, could be getting a falsely high reading if they use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) blood glucose testing strips. The strips, manufactured by Roche, Abbott Laboratories, and other companies, may detect non-glucose sugars and cause patients to risk an insulin overdose. The FDA says most of the strips are used in nursing homes and hospitals, and they include brands such as Roche's Accu-Chek Comfort Curve test strips and Abbott's Freestyle test strips. Read full story >

See all Diabetes News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyDiabetesCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.